drugset / Trial / NCT06297525
Study of STP938 (Dencatistat) in Advanced Solid Tumours
Non-randomizedSequentialOpen-labelTreatment
Summary
The Phase 1a part of the study is a dose escalation of STP938 as a monotherapy. The Phase 1b part of the study is a safety expansion cohort of STP938 as a monotherapy.
Timeline
- Start
- 2024-08-02
- Primary completion
- 2026-12
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STP938 | Small molecule | — | Oral |